Total raised
—
Last: Undisclosed 2021-09
Stage
Seed
Founded
2021
Headcount
6
HQ
Caesarea
Sector
Health Tech & Life Sciences
About
PsygaBio is a drug discovery company focused on developing therapeutics derived from natural compounds.
Using Cannasoul's proprietary analytical platform, PsygaBio's data-driven approach, know-how, and clinical trial framework support active compound identification and development, from mushroom cultivation and extraction to clinically approved formulations.
PsygaBio, in partnership with Cannasoul Analytics, aims to exploit the diversity found in the psychedelic mushroom realm to identify active compounds and formulations for therapeutic benefits.
PsygaBio is a subsidiary of Cannasoul Analytics.
Funding history · 1 round · — total
2021-09
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is PsygaBio's primary focus as a company?
- PsygaBio is a drug discovery company focused on developing therapeutics derived from natural compounds.
- When was PsygaBio founded?
- PsygaBio was founded in April 2021.
- What is PsygaBio's relationship with Cannasoul Analytics?
- PsygaBio is a subsidiary of Cannasoul Analytics and partners with them to identify active compounds and formulations from psychedelic mushrooms for therapeutic benefits.
- What kind of analytical platform does PsygaBio utilize for its drug discovery?
- PsygaBio uses Cannasoul's proprietary analytical platform for active compound identification and development.
- Has PsygaBio raised any funding, and if so, from whom?
- PsygaBio raised an Undisclosed round in September 2021, with NFX Capital as an investor. For full financing history, refer to startupim.
- What is the current employee count for PsygaBio?
- PsygaBio currently has 6 employees.
- Who is a known founder of PsygaBio?
- Shmuel Mandel is a founder of PsygaBio.
- What is PsygaBio's current product stage?
- PsygaBio's product is currently in the R&D stage.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Technologies
BiologicalsCellsHerbals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Tags
geneticspharmaceuticals